Closed
SectorHealthcare
5.67
24h
Min
5.66
Max
5.76
Income | 11M -35M |
|---|---|
Sales | 13M 17M |
Profit margin | -203.272 |
Employees | 596 |
EBITDA | 769K -39M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +62.54% upside |
Next Earnings | 6 Nov 2025 |
|---|
Market Cap | 456M 1.8B |
|---|---|
Previous open | 5.67 |
Previous close | 5.67 |
By Acuity
60%
40%
309 / 371 Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 9.2 USD 62.54%
High 17 USD
Low 5 USD
Based on 7 Wall Street analysts offering 12 month price targets forAbCellera Biologics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$